Cognitive Dysfunction
331
75
93
139
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
28 trials with published results (8%)
Research Maturity
139 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
9 terminated out of 331 trials
93.9%
+7.4% vs benchmark
5%
15 trials in Phase 3/4
20%
28 of 139 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 139 completed trials
Clinical Trials (331)
Cognitive Dysfunction and Delirium After TUR-M in Elderly Patients
Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue
Trifecta Research Study
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
Neurocognitive Assessment CNSL and LGG
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
The Better, Harder, Faster, Stronger Study
SGLT2 Inhibitors and Cognitive Function in Adults With Type 2 Diabetes (SaveMinD)
A Multi-Dimensional Comparative Study of Exercise Psychological Experience Under AI Fitness Companion and Human Coach Paradigms
Non-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment
Interventions in Mathematics and Cognitive Skills
Health Ahead Comparative Effectiveness Study
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
Psychological Impacts of Exercise Snacks Versus Traditional Exercise: A Comparative Study
Human Observatory Study
Feasibility Study on the Use of Redormin®500 on Day-time Cognition
Development and Evaluation of Virtual Reality Experiences for Cognitive Stimulation at the Sociosanitary Center El Carme
Polyphenols and Cognitive Decline
100-Year Human Aging Study
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients